BCR

gene product
ALL, BCR1, CML, D22S11, D22S662, PHL
A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
131 antibodies from 16 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
GeneTex
6 antibodies
Novus Biologicals
18 antibodies
Bethyl Laboratories, Inc.
3 antibodies
Cell Signaling Technology, Inc
2 antibodies
Abnova Corporation
8 antibodies
Thermo Fisher Scientific Pierce
5 antibodies
antibodies-online
51 antibodies
Acris Antibodies GmbH
7 antibodies
Epitomics
3 antibodies
Creative Biomart
13 antibodies
BioLegend
4 antibodies
LifeSpan BioSciences, Inc.
6 antibodies
Atlas Antibodies
1 antibody
Proteintech Group
1 antibody
GenWay
2 antibodies
Sigma-Aldrich
1 antibody